Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A S Merseburger

Showing results (41-50 of 79) with videos related to

Pageof 8
Sort By:
Der Urologe. Ausg. A|March 4, 2008
[Use of a gelatine-thrombin matrix for closure of the access tract without a nephrostomy tube in minimally invasive percutaneous nephrolitholapaxy]D Schilling, B Winter, A S Merseburger, et al.
Aktuelle Urologie|August 23, 2012
[Partial nephrectomy after neoadjuvant administration of sunitinib facilitates preservation of a solitary kidney]C von Klot, J U Becker, V Grünwald, et al.
World Journal of Urology|February 10, 2011
Waterjet hydrodissection: first experiences and short-term outcomes of a novel approach to bladder tumor resectionU Nagele, M Kugler, A Nicklas, et al.
World Journal of Urology|January 25, 2011
Response of renal lesions during systemic treatment with sunitinib in patients with metastatic renal cell carcinoma: a single center experience with 14 patientsC Seidel, M Fenner, A S Merseburger, et al.
Der Urologe. Ausg. A|November 18, 2017
[Inhibitors of the androgen receptor N‑terminal domain : Therapies targeting the Achilles' heel of various androgen receptor molecules in advanced prostate cancer]M C Hupe, A Offermann, F Perabo, et al.
Der Urologe. Ausg. A|November 30, 2019
[Changes in the treatment of metastatic prostate cancer-new data and open questions]P Albers, M Bögemann, S Machtens, et al.
Der Urologe. Ausg. A|March 15, 2017
[The Lubeck medical consultation bag]M C Hupe, M J P Hennig, J P Struck, et al.
Der Urologe. Ausg. A|January 20, 2011
[Bladder cancer update: what was new at the 2010 annual congress of the German Association of Urology in Düsseldorf?]R Nawroth, A Hartmann, P J Olbert, et al.
Der Urologe. Ausg. A|August 19, 2008
[Minimally invasive percutaneous nephrolitholapaxy (MIP)]U Nagele, D Schilling, A G Anastasiadis, et al.
Cancer Genomics & Proteomics|August 10, 2019
Reduced Expression of the Cell Cycle Regulator p27<sup>Kip1</sup> within the Invasion Front of Renal Cell Carcinomas Proved to be a Significant Marker for Disease-specific SurvivalA S Merseburger, E VON DER Heyde, A Kobierski, et al.
Pageof 8

Showing results (41-50 of 79) with videos related to

Sort By:
Pageof 8
Der Urologe. Ausg. A|March 4, 2008
[Use of a gelatine-thrombin matrix for closure of the access tract without a nephrostomy tube in minimally invasive percutaneous nephrolitholapaxy]D Schilling, B Winter, A S Merseburger, et al.
Aktuelle Urologie|August 23, 2012
[Partial nephrectomy after neoadjuvant administration of sunitinib facilitates preservation of a solitary kidney]C von Klot, J U Becker, V Grünwald, et al.
World Journal of Urology|February 10, 2011
Waterjet hydrodissection: first experiences and short-term outcomes of a novel approach to bladder tumor resectionU Nagele, M Kugler, A Nicklas, et al.
World Journal of Urology|January 25, 2011
Response of renal lesions during systemic treatment with sunitinib in patients with metastatic renal cell carcinoma: a single center experience with 14 patientsC Seidel, M Fenner, A S Merseburger, et al.
Der Urologe. Ausg. A|November 18, 2017
[Inhibitors of the androgen receptor N‑terminal domain : Therapies targeting the Achilles' heel of various androgen receptor molecules in advanced prostate cancer]M C Hupe, A Offermann, F Perabo, et al.
Der Urologe. Ausg. A|November 30, 2019
[Changes in the treatment of metastatic prostate cancer-new data and open questions]P Albers, M Bögemann, S Machtens, et al.
Der Urologe. Ausg. A|March 15, 2017
[The Lubeck medical consultation bag]M C Hupe, M J P Hennig, J P Struck, et al.
Der Urologe. Ausg. A|January 20, 2011
[Bladder cancer update: what was new at the 2010 annual congress of the German Association of Urology in Düsseldorf?]R Nawroth, A Hartmann, P J Olbert, et al.
Der Urologe. Ausg. A|August 19, 2008
[Minimally invasive percutaneous nephrolitholapaxy (MIP)]U Nagele, D Schilling, A G Anastasiadis, et al.
Cancer Genomics & Proteomics|August 10, 2019
Reduced Expression of the Cell Cycle Regulator p27<sup>Kip1</sup> within the Invasion Front of Renal Cell Carcinomas Proved to be a Significant Marker for Disease-specific SurvivalA S Merseburger, E VON DER Heyde, A Kobierski, et al.
Pageof 8